This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Patheon Softgels Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Henricus Van Duijnhoven: Innovator in Enteric Soft Capsule Technology
Introduction
Henricus Van Duijnhoven, based in Den Bosch, Netherlands, is a notable inventor recognized for his innovative contributions to the field of pharmaceuticals. With a focus on developing all-natural enteric soft capsules, Van Duijnhoven has made significant strides in enhancing medication delivery systems.
Latest Patents
Van Duijnhoven holds a patent for all-natural enteric soft capsules, which are characterized by their unique composition of cationic Type A gelatin and acid-insoluble enteric polymers. This patent outlines advanced methods for manufacturing these soft capsules, particularly those incorporating active ingredients like non-steroidal anti-inflammatory drugs (NSAIDs) and omega-3 fatty acids. His work is instrumental in providing more effective and natural alternatives for patients.
Career Highlights
Henricus is currently affiliated with Patheon Softgels Inc., a company renowned for its excellence in delivering dosage forms. His expertise in the formulation of enteric soft capsules has positioned him as a key figure in the research and development of innovative pharmaceutical products.
Collaborations
Throughout his career, Henricus Van Duijnhoven has worked alongside esteemed colleagues such as Yunhua Hu and Martin Piest. Their collaborative efforts have fostered an environment of innovation, contributing to the development of advanced soft capsule technologies.
Conclusion
Henricus Van Duijnhoven’s innovative spirit and dedication to improving pharmaceutical formulations through all-natural enteric soft capsules exemplify his impact on the industry. As he continues to lead advancements in this area, his work will undoubtedly benefit countless patients seeking effective and natural medication options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile